Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oshadi D and Oshadi R + Docetaxel in 2nd Line Metastatic NSCLC
NCT02134990Phase 2Unknown
- Sponsor
- Oshadi Drug Administration Ltd.
- Start
- Jun 2014
- Primary completion
- Jan 2019
- Modality
- Nanoparticles, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Deoxyribonuclease in Oshadi carrier, oshadi r in non-small cell lung cancer (NSCLC), sponsored by Oshadi Drug Administration Ltd.. Status: unknown.
02
Drugs
Deoxyribonuclease in Oshadi carrieroshadi r
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02134990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02134990.